1. Late phase II clinical study of acetyl cholinesterase inhibitor E2020 in patients with Alzheimer-type dementia;Homma;Clinical Evaluation,1998
2. Homma A, Takeda M, Imai Y, Udaka F, Hasegawa K, Kameyama M, Nishimura T, Tohgi H, Yamazaki E, Totsuka S, Otani K, Kawakatsu S, Takeuchi H, Kubo K, Maruki Y, Ueki A, Otuska M, Araki T, Asai K, Abe T, Someya Y, Hirai S, Kato M, Mimura M, Hirasawa H, Koyama K, Isse K, Uno M, Asada T, Takayama Y, Tanaya K, Odagiri T, Ishii T, Aoba A, Kosaka A, Murasaki M, Otani Y, Shinohara Y, Tachikawa H, Imai N, Hamanaka T, Nakanishi M, Ojika K, Fujita S, Yamada K, Kamimoto K, Yamada T, Takada K, Uchida M, Watanabe Y, Takahashi N, Kurachi M, Suzuki M, Koshino Y, Kobayashi K, Jibiki I, Sugawara K, Isaki K, Fukutani Y, Kuzuhara S, Narita Y, Naito Y, Murai K, Matsuyama M, Fujimoto N, Narita M, Miyoshi K, Nakajima K, Mori S, Tada K, Nakamura Y, Ogihara T, Miki T, Imai T, Takahashi M, Nishimoto K, Yamamoto H, Yamamoto T, Moro E, Hashimoto M, Tanimukai S, Ikejiri Y, Morita Y, Terao A, Yasuda T, Funakawa I, Sasaki K, Fujisawa Y, Nakamura S, Katayama S, Yoshinaga J, Takahashi K, Nakashima K, Urakami K, Ishino H, Miyaoka T, Kobayashi S, Ikeda H, Inoue S, E2020 Study Group Clinical efficacy and safety of donepezil on cognitive and global function in patients with Alzheimer's disease: A 24-week, multicenter, double-blind, placebo-controlled study in Japan Dementia and Geriatric Cognitive Disorders 2000 299 313
3. Friedhoff LT Ieni JR Rogers SL Pratt RD Donepezil provides long-term clinical benefits for patients with Alzheimer's Disease Proceedings of the 21st Collegium Internationale Neuro psychopharmacologicum;1998 Jul 12-16, Glasgow, Scotland 1998 ABSTRACT REF: PW11017 SR-HANDSRCH
4. Friedhoff LT Rogers SL Correlation between the clinical efficacy of donepezil HCL (E2020) and red blood cell (RBC) Acetylcholinesterase (ACHE) inhibition in patients with Alzheimer's disease Proceedings of the 98th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics; 1997 Mar 5-8, San Diego 1997 6 7
5. Rogers S Perdomo C Friedhoff L Clinical Benefits are Maintained During Long-term Treatment of Alzheimer's Disease with the Acetylcholinesterase Inhibitor, E2020 Proceedings of the 8th European College of Neuropsychopharmacology Congress; 1995 Sep 30-Oct 4, Venice 1995 SR-HANDSRCH